Antitrust

China's antitrust regulator has launched an official investigation campaign to unravel the complex supply and distribution networks of drugs and medical devices. Healthcare firms will need to ensure proper pricing conduct and prepare for the surveys and raids

O'Melveny & Myers

O'Melveny & Myers

China's antitrust regulator has set firm standards in an industry long criticized for market power imbalances among car manufacturers, distributors and suppliers. The new rules require thorough compliance checks and reexamining of all vertical relationships 中国反垄断监管机构已针对长期受制造商、经销商和供应商间市场力量失衡诟病的汽车业设立严格标准。新规定要求对所有垂直关系进行全面合规检查和复查。

Issued: March 25 2016 Main contents: The Guidelines expressly prohibit reverse price monopoly acts by assembled vehicle manufacturers, include…

The proposed Anti-unfair Competition Law amendment strikes a harsher tone on commercial bribery, sets clearer punishment standards and imposes greater compliance burdens on companies

O'Melveny & Myers

O'Melveny & Myers

O'Melveny & Myers